Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bendszus

Showing results (631-640 of 671) with videos related to

Pageof 68
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Nature Cancer|July 1, 2026
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trialLukas Bunse, Katharina Lindner, Antje Wick, et al.
Frontiers in Neurology|October 10, 2024
Safety and effectiveness of SOFIA/SOFIA PLUS for direct aspiration as first line treatment in patients with acute anterior ischemic stroke: results from the prospective, multicentric SESAME studyUlf Neuberger, Gaultier Marnat, Xavier Barreau, et al.
The Lancet. Oncology|January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working groupD Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
Nature|March 25, 2021
A vaccine targeting mutant IDH1 in newly diagnosed gliomaMichael Platten, Lukas Bunse, Antje Wick, et al.
NPJ Precision Oncology|November 27, 2025
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation studyJulius M Kernbach, Urte Schroeder, Karlijn Hakvoort, et al.
The Lancet. Oncology|May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomasMichael Weller, Martin van den Bent, Jörg C Tonn, et al.
Nature Communications|February 11, 2023
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticlesVerena Turco, Kira Pfleiderer, Jessica Hunger, et al.
The Lancet. Oncology|April 7, 2019
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective studyPhilipp Kickingereder, Fabian Isensee, Irada Tursunova, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 23, 2022
Outcome prediction in large vessel occlusion ischemic stroke with or without endovascular stroke treatment: THRIVE-EVTAlexander C Flint, Sheila L Chan, Nancy J Edwards, et al.
Pageof 68

Showing results (631-640 of 671) with videos related to

Sort By:
Pageof 68
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Nature Cancer|July 1, 2026
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trialLukas Bunse, Katharina Lindner, Antje Wick, et al.
Frontiers in Neurology|October 10, 2024
Safety and effectiveness of SOFIA/SOFIA PLUS for direct aspiration as first line treatment in patients with acute anterior ischemic stroke: results from the prospective, multicentric SESAME studyUlf Neuberger, Gaultier Marnat, Xavier Barreau, et al.
The Lancet. Oncology|January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working groupD Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
Nature|March 25, 2021
A vaccine targeting mutant IDH1 in newly diagnosed gliomaMichael Platten, Lukas Bunse, Antje Wick, et al.
NPJ Precision Oncology|November 27, 2025
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation studyJulius M Kernbach, Urte Schroeder, Karlijn Hakvoort, et al.
The Lancet. Oncology|May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomasMichael Weller, Martin van den Bent, Jörg C Tonn, et al.
Nature Communications|February 11, 2023
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticlesVerena Turco, Kira Pfleiderer, Jessica Hunger, et al.
The Lancet. Oncology|April 7, 2019
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective studyPhilipp Kickingereder, Fabian Isensee, Irada Tursunova, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 23, 2022
Outcome prediction in large vessel occlusion ischemic stroke with or without endovascular stroke treatment: THRIVE-EVTAlexander C Flint, Sheila L Chan, Nancy J Edwards, et al.
Pageof 68